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The dopamine receptor system plays a key role in numerous neuropsychiatric and neurological disorders. The D 3 receptor, first described in 1990, 1 is a member of the D 2 -like receptor family, and possesses about 50% overall homology to the D 2 receptor subtype.
2 D 3 receptors are localized in the limbic areas of the brain, specifically in the group of neural granule cells located within the ventral striatum in the brains of most animals. 3 In the field of medicinal chemistry extensive efforts have been made to explore potent and selective ligands for dopamine D 3 1 or D 4 4 receptor for the discovery of antipsychotic drugs.
5 Currently, much research effort is being focused on the discovery of highly selective dopamine D 4 receptor ligands. 6 The reason for the interest in this area is derived from the possible involvement of D 4 receptor in schizophrenia. [7] [8] [9] [10] In connection with search for selective ligands for various GPCRs, we have recently reported 11 the design and synthesis of arylpiperazine derivative libraries as dopamine receptor antagonist and serotonine receptor antagonist with isoxazole rings. In continuation of our efforts to search for selective GPCR ligands, we envisaged a library of piperidinylpiperazine derivatives with isoxazole rings as a plausible candidate for the purpose. Herein we wish to report the construction of a small focused library of isoxazolylpiperidinylpiperazines and their binding affinities for dopamine D 3 and D 4 receptors.
The synthesis of isoxazolylpiperidinylpiperazine derivatives is shown in Schemes 1, 2 and 3. The synthetic strategy to these compounds involved reductive amination between two building blocks 5 and 9.
For the acquisition of building block 5, the amino group of Scheme 1. Synthesis of building block 5.
Scheme 2. Synthesis of building block 9.
Scheme 3. Synthesis of scaffold (isoxazolylpiperidinylpiperazine).
Notes
piperidin-2-ylmethanol 1 was first protected by (t-Boc) 2 O in dichloromethane at 0 o C and then at rt to give compound 2 in 90% yield. Compound 2 was then oxidized with PCC and SiO 2 in dichloromethane at rt for 5 h into aldehyde 3 in 72% yield. The aldehyde 3 was reacted with piperazine derivatives using NaBH(OAc) 3 in presence of 4 Å molecular sieve over 5 h to afford compounds 4 in 64-88% yields. Finally building block 5 was obtained in quantitative yield by a simple deprotection reaction with CF 3 CO 2 H in dichloromethane at rt.
With building block 5 in hand, we moved to our next building block 9. Treatment of aldehydes 6 with hydroxylamine hydrochloride and pyridine at rt for 1-4 h gave oximes 7 in 81-100% yields. Isoxazole nucleus was generated by two-step sequence of nitrile oxide cycloaddition reaction which involved (1) chlorination of 7 with N-chlorosuccinimide and (2) in situ generation of nitrile oxide and cycloaddition with propargyl alcohol. In this way isoxazole alcohols 8 were obtained in 50-81% yields. Subsequent PCC oxidation of 8 afforded building block 9 in 60-79% yields. Employing the developed combinatorial protocol, 12 synthesis of isoxazolylpiperidinylpiperazine derivatives 10 was finally accomplished by simple reductive amination reaction between building blocks 5 and 9 using NaBH(OAc) 3 
13
(Scheme 3). Thus prepared isoxazolylpiperidinylpiperazine products are shown in Table 1 . Structures and purities of products were confirmed by 1 H NMR,
C NMR, IR, MS spectroscopic analysis and HPLC.
Thus, a small focused library of diverse compounds 10 was constructed and tested for binding affinities 14 for dopamine D 3 and D 4 receptors. As shown in Table 2 most of the compounds exhibited IC 50 values below 5 µM which will be the key factor for further research in this field. Compound 10-3 (entry 3, when R 1 is phenyl and R 2 is 2-methoxyphenyl) showed a good activity for dopamine D 3 (3.1 µM) and D 4 (1.1 µM). Among the prepared compounds, compound 10-12 (entry 12, when R 1 is 2-fluorophenyl and R 2 is benzo-1,3-dioxole) showed best binding affinity for dopamine D 3 receptor (0.7 µM) and good activity towards D 4 receptor (1.4 µM). Compound 10-11 (entry 11), in which R 2 of compound 10-12 is replaced by 4-methylphenyl, also exhibited good binding activities but selective affinity for D 4 receptor (1.4 µM) over D 3 receptor (5.3 µM ). When R 1 is 3-chlorophenyl a dramatic change of activity was observed as follows: While compound 10-15 (entry 15, when both R 1 and R 2 are 3-chlorophenyl) showed good activity only towards dopamine D 3 receptor (2.2 µM) compared to dopamine D 4 receptor (>10 µM), compound 10-20 (entry 20, when R 1 is 3-chlorophenyl but R 2 is benzo-1,3-dioxole) exhibited completely opposite results (>10 µM for dopamine D 3 receptor and 5.5 µM for dopamine D 4 receptor). It is also noteworthy that compound 10-25 (entry 25), in which R 1 is bis(fluorophenyl)methyl and R 2 is 2-fluorophenyl, showed good activity (1.6 µM) for dopamine D 3 receptor. In our previous research 11a some piperazinylalkylisoxazole compounds had excellent binding affinities. We envisaged that introduction of any heterocycle with nitrogen in between piperazine and isoxazole may increase the binding affinity. However such notion proved unsuccessful in case of the heterocycle being piperidine as the binding results indicated. Nonetheless it is interesting to note that fluoro compounds show better binding affinities for dopamine D 3 and dopamine D 4 receptors than other derivatives.
In summary we have synthesized a small focused library of isoxazolylpiperidinylpiperazine compounds and tested them in vitro 14 for dopamine D 3 and D 4 receptor binding affinities. The results might be helpful for the future research in the design and synthesis of potent and selective ligands for dopamine D 3 or D 4 receptors.
Experimental Section
General Procedure for Synthesis of Building Block 5 (when R 1 = Ph). To a solution of compound 3 (481 mg, 2.25 mmol) in dichloromethane (20 mL) at rt, 1-phenylpiperazine (444 μL, 2.92 mmol) and 4 Å molecular sieve were added. After the mixture being stirred for 5 min, NaBH(OAc) 3 (1.43 g, 6.74 mmol) was added and the mixture was stirred for 5 h. Saturated NaHCO 3 solution was added and the mixture was extracted with ethyl acetate (50 mL × 3). The organic layers were dried over anhydrous MgSO 4 and concentrated. The residue was purified by flash column chromatography (Hexane:EtOAc = 4:1) to give the compound 4 (when R 1 = Ph, 531 mg, 66%).
To a solution of thus prepared compound 4 (447 mg, 1.24 mmol) in dichloromethane at rt, trifluoroacetic acid (958 μL, 12.4 mmol) was added. After the mixture being stirred for 3 h, saturated NaHCO 3 solution was added and the mixture was extracted with ethyl acetate (50 mL × 3). The organic layers were dried over anhydrous MgSO 4 and concentrated. Removal of organic solvents from the residue gave the building block 5 (320 mg, 100%). General Procedure for Synthesis of Building Block 9 (when R 2 = 2-methoxyphenyl). To a solution of 2-methoxybenzaldehyde oximes 7 (when R 2 = 2-methoxyphenyl, 302 mg, 2.00 mmol) in THF (7 mL) at rt under nitrogen atmosphere, N-chlorosuccinimide (534 mg, 2.00 mmol) and pyridine (16.0 μL, 0.20 mmol) were added. After being stirred for 1 h at 60 o C, the mixture was cooled to rt and a solution of propargyl alcohol (116 μL, 2.00 mmol) in THF (2 mL) and triethylamine (335 μL, 2.40 mmol) in THF (2 mL) were added dropwise successively. After the mixture being stirred at 50 o C for 3 h, saturated NaHCO 3 solution was added and the mixture was extracted with ethyl acetate (50 mL × 3). The organic layers were dried over anhydrous MgSO 4 and concentrated. The residue was purified by flash column chromatography (Hexane:EtOAc = 1:1) to give the isoxazole alcohol 8 (333 mg, 81%).
To a solution of thus prepared alcohol 8 (when R 2 = 2-methoxyphenyl, 261 mg, 1.27 mmol) in dichloromethane (10 mL) at rt, pyridinium chlorochromate (548 mg, 2.54 mmol) and silica gel (230-400 mesh, 548 mg) were added. After being stirred for 6 h, the mixture was filtered through Florisil column. The filtrate was concentrated and the residue was purified by flash column chromatography (Hexane:EtOAc = 2:1) to give the building block 9 (when R 2 = 2-methoxyphenyl, 195 mg, 76%). General Procedure for Synthesis of Isoxazolylpiperidinylpiperazine derivatives 10 (when R 1 = Ph and R 2 = 2-methoxyphenyl). To a solution of building block 5 (when R 1 = Ph, 45.0 mg, 0.17 mmol) and building block 9 (when R 2 = 2-methoxyphenyl, 32.0 mg, 0.16 mmol) in dichloromethane (3 mL) at rt, 4 Å molecular sieve was added. After the mixture being stirred for 10 min, NaBH(OAc) 3 (100 mg, 0.47 mmol) was added and the mixture was stirred for 5 h. Saturated NaHCO 3 solution was added and the mixture was extracted with ethyl acetate (5 mL × 5). The organic layers were dried over anhydrous MgSO 4 and concentrated. The residue was purified by flash column chromatography (EtOAc) to give the isoxazolylpiperidinylpiperazine 10 (when R 1 = Ph and R 2 = 2-methoxyphenyl, 45.6 mg, 65%). Other isoxazolylpiperidinylpiperazine derivatives were synthesized analogously and identified with the 1 H NMR,
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C NMR, IR, and MS spectroscopies.
